112575 ⎘
Measuring or testing processes involving enzymes, nucleic acids or microorganisms ; Compositions therefor; Processes of preparing such compositions involving lyase
Genetically Engineered Yeast Producing 3-Hydroxypropionic Acid at Low pH
#2A Novel Chemogenetic Tool Permitting Modulation of Intracellular pH
#3BIOMARKERS OF FIBROSIS AND USES THEREFOR
#4ELEVATION OF GLYCOSAMINOGLYCANS IN SUBJECTS WITHOUT MUCOPOLYSACCHARIDOSIS
#5METHODS FOR DIAGNOSIS AND TREATMENT OF ALZHEIMER'S DISEASE
#6METHODS OF IDENTIFYING AND/OR CHARACTERIZING A POLYNUCLEOTIDE OF INTEREST
#7APPARATUS AND METHODS USING TETHERED ENZYMES FOR THE DETECTION OF THE ENZYMATIC ACTIVITY OF BIOMARKERS
#8COMBINATORIAL HIGH-THROUGHPUT SCREENING OF COMPLEX POLYMERIC ENZYME IMMOBILIZATION SUPPORTS
#9METHOD OF DETECTING EPIGENETIC MODIFICATION
#10MINIMALLY-INVASIVE MEASUREMENT OF ESOPHAGEAL INFLAMMATION
#11ACETAMINOPHEN PROTEIN ADDUCTS AND METHODS OF USE THEREOF
#12BACTERIA FOR THE TREATMENT OF DISORDERS
#13METHOD FOR OBTAINING DOUBLE-STRANDED SEQUENCE BY SINGLE-STRANDED ROLLING CIRCLE AMPLIFICATION
#14METHOD FOR QUANTIFYING PHENYLALANINE IN BLOOD, AND MEASUREMENT KIT USED THEREFOR
#15SYSTEMS AND METHODS FOR MEASURING CELL SIGNALING PROTEIN ACTIVITY
#16Apparatus and methods using tethered enzymes for the detection of the enzymatic activity of biomarkers
#17ANALYSIS APPARATUS AND ANALYSIS METHOD
#18SYSTEMS AND METHODS FOR MEASURING CELL SIGNALING PROTEIN ACTIVITY
#19BACTERIA ENGINEERED TO REDUCE HYPERPHENYLALANINEMIA
#20SCREENING METHOD FOR THE IDENTIFICATION OF NOVEL THERAPEUTIC COMPOUNDS
#21Mutated histidine decarboxylase and use thereof
#22APPLICATION OF MICROBIAL GLYCOSIDASE AS AN ANTI-VIRAL THERAPEUTIC, PROGNOSTIC, AND DIAGNOSTIC
#23Screening method
#24DETECTION OF ANALYTE
#25SYSTEMS AND METHODS FOR MEASURING CELL SIGNALING PROTEIN ACTIVITY
#26ELUTION OF MICROPARTICLES BY SIZE EXCLUSION CHROMATOGRAPHY USING WATER AS A MOBILE PHASE
#27CRYSTALLIZED OXALATE DECARBOXYLASE AND METHODS OF USE
#28System and method for detecting a target enzyme
#29Genetically modified bacteria producing three DNA repair enzymes and method for the evaluation of DNA repair activity
#30MEDIUM FOR THE SPECIFIC DETECTION OF RESISTANT MICROORGANISMS
#31ENGINEERED TYROSINE AMMONIA LYASE
#32Phosphoketolases for improved production of acetyl coenzyme A-derived metabolites, isoprene, isoprenoid precursors, and isoprenoid
#33Screening method
#34METHODS OF DIAGNOSING A DISEASE AND METHODS OF MONITORING TREATMENT OF A DISEASE BY QUANTIFYING A NON-REDUCING END GLYCAN RESIDUAL COMPOUND AND COMPARING TO A SECOND BIOMARKER
#35DETECTION OF OLIGOSACCHARIDES
#36Minimally-invasive measurement of esophageal inflammation
#37Compositions and methods for producing lipids and other biomaterials from grain ethanol stillage and stillage derivatives
#38Bacteria for the treatment of disorders
#39CRYSTALLIZED OXALATE DECARBOXYLASE AND METHODS OF USE
#405-ALA for detection of brain tumors
#41Engineered enzymes with methionine-gamma-lyase enzymes and pharmacological preparations thereof
#42Medium for the specific detection of resistant microorganisms
#43Polynucleotides encoding engineered tyrosine ammonia lyase variants
#44Mutated histidine decarboxylase and use thereof
#45Phosphoketolases for improved production of acetyl coenzyme A-derived metabolites, isoprene, isoprenoid precursors, and isoprenoids
#46Acetaminophen adducts and methods of use thereof
#47Quantification of non-reducing end glycan residual compounds for determining the presence, identity, or severity of a disease or condition
#48Engineered tyrosine ammonia lyase
#49PHYSICOCHEMICAL MODIFICATION AND APPLICATION OF ALGINATE GELS FOR THE CONTROLLED RELEASE OF REAGENTS IN CLASSICAL SOLUTION ASSAYS AND MICROFLUIDIC ASSAYS
#50Minimally-invasive measurement of esophageal inflammation
#51Systems and methods for determining cyclic nucleotide concentration and related pathway activation
#52Bacteria engineered to reduce hyperphenylalaninemia
#53Staphylococcus lysin and use thereof
#54Method for identifying polyubiquitinated substrate
#55Methods of diagnosing mucopolysaccharidosis (MPS) I and methods of monitoring treatment of MPS by quantifying a non-reducing end glycan residual compound and comparing to a second biomarker
#56CRYSTALLIZED OXALATE DECARBOXYLASE AND METHODS OF USE
#57Compositions and methods for producing lipids and other biomaterials from grain ethanol stillage and stillage derivatives
#58CROSS-LINKED POLYMER MATRICES, AND METHODS OF MAKING AND USING SAME
#59Crystallized oxalate decarboxylase and methods of use
#60Methods and composition for modifying enzymes
#61In vitro production of cyclic peptides
#62Engineered enzymes with methionine-gamma-lyase enzymes and pharmacological preparations thereof
#63Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of leucyl-tRNA synthetases
#64Detection of oligosaccharides
#65Heparinases obtained from , preparation therefor and application thereof
#66ENZYMES THAT CLEAVE NON-GLYCOSIDIC ETHER BONDS BETWEEN LIGNINS OR DERIVATIVES THEREOF AND SACCHARIDES
#67Enzymes and methods for styrene synthesis
#68Device, system and method for cancer prognosis and uses thereof
#69Lanthanide toolbox for organelle specific molecular imaging
#70Quantification of non-reducing end glycan residual compounds for determining the presence, identity, or severity of a disease or condition
#71MEDICAMENT DESIGN POCKET OF ORNITHINE DECARBOXYLASE AND APPLICATION OF MEDICAMENT DESIGN POCKET
#72COMPOSITIONS AND METHODS OF SELECTIVELY INHIBITING IRP1 AND TREATING INFLAMMATION
#73Acetaminophen adducts and methods of use thereof
#74Use of a N-acetylneuraminate lyase derived from the bacterium in the production of neuraminic acid and derivatives thereof
#75Polynucleotides encoding engineered tyrosine ammonia lyase variants
#76Activity of Fe—S cluster requiring proteins
#77Minimally-invasive measurement of esophageal inflammation
#78Medium for the specific detection of resistant microorganisms
#79SCHIFF-BASE CONJUGATE OF N, N-DIBUTYL-P-PHENYLENEDIAMINE WITH PYRIDOXAL 5'-PHOSPHATE FOR IMPROVED HOMOCYSTEINE ASSAYS USING PYRIDOXAL 5'-PHOSPHATE-DEPENDENT ENZYMES
#80Assay and method for quantitating carbonic anhydrase activity and assessing red blood hemolysis
#81MICROWELL PLATE FOR HIGH-THROUGHPUT DETECTION AND APPLICATION THEREOF
#82Methods of determining the presence, identity, and/or severity of mucopolysaccharidosis (MPS) VI and IVA
#835-ALA FOR DETECTION OF BRAIN TUMORS
#84Liposomal detection devices and methods for their use and preparation
#85NANOSENSOR FOR DETECTING THE ACTIVITY OF GLYCOSAMINOGLYCAN-CLEAVING ENZYMES AND USES THEREOF
#86Engineered enzymes with methionine-gamma-lyase enzymes and pharmacological preparations thereof
#87COLORIMETRIC ASSAY FOR L-GLUTAMINE AND RELATED ASSAY KIT
#88Quantification of non-reducing end glycan residual compounds for determining the presence, identity, or severity of a disease or condition
#89Onion with reduced pungency that does not generate lachrymatory component
#90Phosphoketolases for improved production of acetyl coenzyme A-derived metabolites, isoprene, isoprenoid precursors, and isoprenoids
#91Crystallized oxalate decarboxylase and methods of use
#92Compositions and Methods For Analysis of C02 Absorption
#93Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of leucyl-tRNA synthetases
#94Enzymes that cleave non-glycosidic ether bonds between lignins or derivatives thereof and saccharides
#95Physicochemical modification and application of alginate gels for the controlled release of reagents in classical solution assays and microfluidic assays
#96IN VITRO PRODUCTION OF CYCLIC PEPTIDES
#97Mucopolysaccharidosis IVA/VII screening and treatment method
#98Detection of oligosaccharides
#99MEDIUM FOR THE SPECIFIC DETECTION OF RESISTANT MICROORGANISMS
#100Use of ADCY3 for diagnosis and treatment of gastric cancer
#101METHOD FOR DETERMINING BREAST CANCER
#102Terpene synthases from
#103Crystallized oxalate decarboxylase and methods of use
#104Methods of diagnosing a disease and methods of monitoring treatment of a disease by quantifying a non-reducing end glycan residual compound and comparing to a second biomarker
#105METHODS AND COMPOSITIONS RELATING TO MEVALONATE PHOSPHATE DECARBOXYLASE
#106Antibiotic and anti-parasitic agents that modulate class II fructose 1,6-bisphosphate aldolase
#107DETECTION AND TREATMENT OF SCHIZOPHRENIA
#108Method for the determination of the concentration of vitamin B6 in a sample
#109Quantification of non-reducing end glycan residual compounds for determining the presence, identity, or severity of a disease or condition
#110CROSS-LINKED POLYMER MATRICES, AND METHODS OF MAKING AND USING SAME
#111Small molecule malarial Aldolase-TRAP enhancers and glideosome inhibitors
#112Enzymatic biosensing systems
#113Terpene synthases from
#114Schiff-base conjugate of N, N-dibutyl-P-phenylenediamine with pyridoxal 5′-phosphate for improved homocysteine assays using pyridoxal 5′-phosphate-dependent enzymes
#115Inhibitors of Mycobacterium Tuberculosis Malate Synthase, Methods of Making and Uses Thereof
#116Fluorescent substrate for detection of enzymatic activity of nitrile-related enzyme
#117Activity of Fe-S cluster requiring proteins
#118Activity of Fe—S cluster requiring proteins
#119VISUAL SCREENING FOR ENZYMES ON THE PHENYLPROPANOID PATHWAY
#120Compositions and methods for monitoring oxalate
#1215-ALA for detection of brain tumors
#122Legume isoprene synthase for production of isoprene
#123BIOMARKER FOR FATIGUE, AND USE THEREOF
#124Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of leucyl-tRNA synthetases
#125Modified carbonic anhydrase enzymes and their use in carbon dioxide sequestration and elimination
#126Protein having glycoalkaloid biosynthetic enzyme activity and gene encoding the same
#127Methods of determining the presence and/or amount of a biomarker to determine the presence, identity, and/or severity of a lysosomal storage or neurological disorder
#128METHOD FOR IDENTIFYING A COMPOUND HAVING AN ANTIARRHYTHMIC EFFECT AS WELL AS USES RELATING THERETO
#129Inhibition of microbial growth by aconitase inhibition
#130Method for screening for S1P lyase inhibitors using cultured cells
#131Method for diagnosing melanocytic proliferations
#132METHIONINE GAMMA LYASE-2-AMINOBUTYRATE DEAMINASE (MEGL-2ABD) AND THERAPEUTIC USES THEREOF
#133Crystallized oxalate decarboxylase and methods of use
#134MEDIUM FOR THE SPECIFIC DETECTION OF RESISTANT MICROORGANISMS
#135METHODS OF DEVELOPING TERPENE SYNTHASE VARIANTS
#136MEDIUM FOR THE SPECIFIC DETECTION OF RESISTANT MICROORGANISMS
#137MEDIUM FOR THE SPECIFIC DETECTION OF RESISTANT MICROORGANISMS
#138D-serine dehydratase and use thereof
#139Inhibition of sweat malodor
#140Terpene synthases from santalum
#141Methods of developing terpene synthase variants
#142Sensitizing agents for cancer therapy, methods of use and methods for the identification thereof
#143Detection and treatment of schizophrenia
#144Activity of Fe—S cluster requiring proteins
#145Methods to Distinguish Different Disaccharide Products after Digestion with Heparinases
#146MODIFIED HEPARINASE III AND METHODS OF SEQUENCING THEREWITH
#147METHOD OF DIAGNOSING ADOLESCENT IDIOPATHIC SCOLIOSIS
#148Probe for detection and quantification of nitric oxide, and method for detecting and quantifying nitric oxide using the same
#149Method for Detecting Metastasis of GI Cancer
#150METHOD OF CLASSIFYING HUMAN SUBJECTS HAVING ADOLESCENT IDIOPATHIC SCOLIOSIS (AIS) AND METHOD FOR SCREENING FOR A COMPOUND USEFUL IN THE TREATMENT OF AIS AND RELATED SYNDROMES CAUSING SPINAL DEFORMITIES
#151Methods and Compositions for Determining Predisposition to Inflammation-Mediated Cardiovascular Disease
#152Engineered enzymes with methionine-gamma-lyase enzymes and pharmacological preparations thereof
#153Methods for cyclic nucleotide determination
#154Compositions and Methods for Spatial Separation and Screening of Cells
#155METHOD OF USING CARBONIC ANHYDRASE TO DETECT HEMOLYSIS
#156Detection and treatment of schizophrenia
#157B-dependent dehydratases with improved reaction kinetics
#158B-dependent dehydratases with improved reaction kinetics
#159Marks as modifiers of the p53 pathway and methods of use
#160GLYCOSAMINOGLYCAN-COATED PARTICLES AND USES THEREOF
#161Minimally-invasive measurement of esophageal inflammation
#162METHOD OF DETERMINING CARBONIC ANHYDRASE I ACTIVITY
#163METHOD, DEVICE AND KIT FOR DETERMINING CONDITIONS RELATED TO A DYSFUNCTION OF THE RENAL PROXIMAL TUBULE
#164D-SERINE DEHYDRATASE AND USE THEREOF
#165Detection of oligosaccharides
#166Quantification of non-reducing end glycan residual compounds
#167SCDs as modifiers of the p53 pathway and methods of use
#168Inhibitors of mycobacterium tuberculosis malate synthase, methods of making and uses thereof
#169SCREENING METHOD
#170DETERMINATION OF CHANGES IN CONCENTRATION
#171Method for Identifying PDE11 Modulators
#172Screening Method for Identifying New Drugs
#173Investigation of mucosa dryness conditions
#174Compositions and methods of therapy for cancers characterized by expression of the tumor-associated antigen mn/ca ix
#175MN and Hypoxia
#176Tetrahydrofolate synthetase gene
#177Method of classifying human subjects having adolescent idiopathic scoliosis
#178SELECTABLE MARKER
#179Fluorescent Assays Using Orthogonal tRNA - Aminoacyl Synthetase Pairs
#180Modified heparinase III and methods of sequencing therewith
#181COMPOSITION FOR ANALYZING DIABETES MELLITUS AND/OR RETINAL VASCULAR DISEASE AND ANALYZING METHOD THEREOF
#182Probe for detection and quantification of nitric oxide, and method for detecting and quantifying nitric oxide using the same
#183Polypeptide complex that regulates cell cycle and anergy
#184Method for increasing body height comprising systemic administration of CNP-53
#185B12 dependent dehydratases with improved reaction kinetics
#186Means and methods for the determination of camp in vitro and in vivo
#187Compositions and methods for treating vascular permeability
#188CA IX-specific inhibitors
#189CA IX-specific inhibitors
#190Methods and compositions for determining predisposition to inflammation-mediated cardiovascular disease
#191MARKs as Modifiers of the p53 Pathway and Methods of Use
#192CA IX-specific inhibitors
#193CA IX-specific inhibitors
#194Medium for the Specific Detection of Resistant Microorganisms
#195CA IX-specific inhibitors
#196CA IX-specific inhibitors
#197Non-antibiotic selection marker genes
#198SCDs As Modifiers of the p53 Pathway and Methods of Use
#199CA IX-specific inhibitors
#200Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
#201Crystallized oxalate decarboxylase and methods of use
#202Isolated human squalene synthase and composition thereof
#203Inhibition of sweat malodor
#204Pressure Transduced Chemical Assay and Method
#205Chemical inhibitors of soluble adenylyl cyclase (sAC)
#206Compositions and methods for the modifying hypoxia induced gene regulation
#20732263, a novel human biotin enzyme and uses thereof
#208Folate Antagonists Having Improved Selectivity
#209Method of determining carbonic anhydrase i activity
#210Method and kits for detecting cerebrospinal fluid in a sample
#211Enzymatic fluorometric assay for cAMP and adenylate cyclase and kits therefor
#212Methods for cyclic nucleotide determination
#213Method for the detection of enzyme-catalyzed cleavage reactions by fluorescence spectroscopy
#214Relationship of a specific metabolite to insulin resistance
#215Cross-linked polymer matrices, and methods of making and using same
#216Alpha enolase-directed diagnostics and therapeutics for cancer and chemotherapeutic drug resistance
#217Rationally designed polysaccharide lyases derived from chondroitinase B
#218Novel Purified dihydrodipicolinate synthase polypeptides and structures thereof
#219Tetrahydrofolate synthetase gene
#220Test methods for determining the intracellular concentration of cyclic nucleotides
#221Methods for assaying for antidepressant therapy markers
#222Composition for the diagnosis of retinal vascular disease comprising aldolase and method for diagnosis using it
#223Compositions and methods for production of sialylated glyoproteins in plants
#224Sialylation of glycoproteins in plants
#225Polynucleotides encoding insect acetyl coenzyme-A carboxylase and uses thereof
#226Compositions of low molecular weight heparin produced with modified heparinase III
#227Methods for preparing low molecular weight heparin with modified heparinase III
#228Eukaryotic genes involved in adult lifespan regulation
#229LIMKs as modifiers of p53 pathway and methods of use
#230Method of screening malt and process for producing foaming malt beverage
#231Uropathogenic D-serine detoxification operon
#232Method for determining inhibition activity of a compound on one of the enzymes of the folate synthesis pathway
#233MN and hypoxia
#234Heparinase III and methods of specifically cleaving therewith
#235CA IX-specific inhibitors
#236Recombinant adenylate cyclase of Bordetella sp. for diagnostic and immunomonitoring uses, method of diagnosing or immunomonitoring using said recombinant adenylate cyclase, and kit for diagnosing or immunomonitoring comprising said recombinant adenylate cyclase
#237Detection assay for potassium ions using a potassium-dependent urea amidolyase enzyme
#238Rationally designed polysaccharide lyases derived from chondroitinase B and methods of specifically cleaving therewith
#239Heparinase III HLGAG fragments and uses thereof
#240Methods for purifying and isolating recombinant chondroitinases
#241Method for screening for activators of soluble guanylate cyclase having oxidized heme iron
#242Scintillation proximity assay method of measuring acetyl CoA carboxylase enzyme activity
#243Pappss as modifiers of the axin pathway and methods of use
#244Chds as modifiers of the p53 pathway and methods of use
#245Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
#246Tryptophan aminotransferase, indole-3-pyruvate decarboxylase and indole-3-acetaldehyde oxidase as novel targets for herbicides
#247Marker for antidepressant therapy and methods related thereto
#248Method of diagnosing adolescent idiopathic scoliosis and related syndromes
#249Determination and quantification of red blood cell populations in samples
#250Method for determining specific groups constituting heparins or low molecular weight heparins
#251Dgks as modifiers of the p53 pathwha and methods of use
#252Method of evaluating pharmacological effects of medicine
#253Phosphorous organic compounds and their use
#254Detection of potassium ions using ion-sensitive enzymes
#255Tryptophan synthase as a site of herbicide action
#256Methods for the identification of inhibitors of acetolactate synthase as antibiotics
#257Method and composition for determining resistance to an acetohydroxy-acid synthase inhibitor
#258Method for detecting catalytic activity
#259Compound embodiments for hydrogen sulfide production and methods of making and using the same
#260Compound embodiments for hydrogen sulfide production and methods of making and using the same
#261Gradient elution moving boundary electrophoresis for use with complex samples and detection of toxins
#262Compounds for carbonyl sulfide/carbon disulfide/hydrogen sulfide release and methods of making and using the same
#263Gradient elution moving boundary electrophoresis for use with complex samples and detection of toxins